Test Bank - Abrams’ Clinical Drug Therapy Rationales for Nursing Practice, 18th Edition (Frandsen, 2025), Chapter 1-61 All Chapters

TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
d d d d d d d



RATIONALES FOR NURSING PRACTICE 12TH EDITION
d d d d d d



GERALYN FRANDSEN
d

,TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
d d d d d d d



RATIONALES FOR NURSING PRACTICE 12TH EDITION
d d d d d d



GERALYN FRANDSEN d




TestdBankdFordAbrams’dClinicaldDrugdTherapydRationalesdfordNursingdPracticed12thdEditiond
GeralyndFrandsend-dISBN/ISSNd9781975136130


TabledofdContent

SECTIONd1dThedConceptualdFrameworkdofdPharmacologydChapt

erd1dThedFoundationdofdPharmacology:dQualitydanddSafetydChapterd2dB

asicdConceptsdanddProcesses

Chapterd3dMedicationdAdministrationdanddthedNursingdProcessdofdDrugdTherapy



SECTIONd2dDrugdTherapydThroughoutdthedLifespan

Chapterd4dPharmacologydanddthedCaredofdInfantsdanddPediatricdPatientsdMedicationdAdministrationdindPedi
atrics

Chapterd5dPharmacologydanddthedCaredofdAdultsdanddGeriatricdPatientsdCh

apterd6dPharmacologydanddthedCaredofdPregnantdordLactatingdWomandChapt

erd7dPharmacologydanddWomen’sdHealth

Chapterd8dPharmacologydanddMen’sdHealth



SECTIONd3dDrugsdAffectingdthedHematopoieticdanddImmunedSystems

Chapterd9dDrugdTherapydfordCoagulationdDisordersdCha

pterd10dDrugdTherapydfordDyslipidemia

Chapterd11dDrugdTherapydfordHematopoieticdDisordersd

Chapterd12dDrugdTherapy:dImmunizations

Chapterd13dDrugdTherapydtodDecreasedImmunitydChapt

erd14dDrugdTherapydfordthedTreatmentdofdCancer

,TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
d d d d d d d



RATIONALES FOR NURSING PRACTICE 12TH EDITION
d d d d d d



GERALYN FRANDSEN d




SECTIONd4dDrugsdAffectingdInflammationdanddInfection

Chapterd15dInflammation,dInfection,danddthedUsedofdAntimicrobialdAgentsd

Chapterd16dDrugdTherapydtodDecreasedPain,dFever,danddInflammationdCha

pterd17dDrugdTherapydWithdCorticosteroids

Chapterd18dDrugdTherapydWithdBeta-

LactamdAntibacterialdAgentsdChapterd19dDrugdTherapydWithdAminoglycos

idesdanddFluoroquinolones

Chapterd20dDrugdTherapydWithdTetracyclines,dSulfonamides,danddUrinarydAntisepticsdCha

pterd21dDrugdTherapydWithdMacrolidesdanddMiscellaneousdAnti-

infectivedAgentsdChapterd22dDrugdTherapydfordTuberculosisdanddMycobacteriumdaviumdCo

mplexdDiseasedChapterd23dDrugdTherapydfordViraldInfections

Chapterd24dDrugdTherapydfordFungaldInfectionsdChapte

rd25dDrugdTherapydfordParasiticdInfections



SECTIONd5dDrugsdAffectingdthedCardiovasculardSystem

Chapterd26dDrugdTherapydfordHypertensiond

Chapterd27dDrugdTherapydfordDysrhythmias

Chapterd28dDrugdTherapydfordCoronarydHeartdDiseased

Chapterd29dDrugdTherapydfordShockdanddHypotensiond

Chapterd30dDrugdTherapydfordHeartdFailure



SECTIONd6dDrugsdAffectingdthedRespiratorydSystem

Chapterd31dDrugdTherapydfordNasaldCongestiondanddCough

Chapterd32dDrugdTherapydtodDecreasedHistaminedEffectsdanddAllergicdResponsedC

, TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
d d d d d d d



RATIONALES FOR NURSING PRACTICE 12TH EDITION
d d d d d d



GERALYN FRANDSEN d

hapterd33dDrugdTherapydfordAsthmadanddBronchoconstriction